PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+23.8%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$376M
AUM Growth
+$376M
(+6.8%)
Cap. Flow
-$14M
Cap. Flow
% of AUM
-3.73%
Top 10 Holdings %
Top 10 Hldgs %
36.6%
Holding
101
New
12
Increased
43
Reduced
26
Closed
20
Top Buys
| 1 |
Humana
HUM
|
$8.93M |
| 2 |
Vaxcyte
PCVX
|
$7.58M |
| 3 |
United Therapeutics
UTHR
|
$5.13M |
| 4 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
$4.93M |
| 5 |
Sarepta Therapeutics
SRPT
|
$4.58M |
Top Sells
| 1 |
CVS Health
CVS
|
$11.2M |
| 2 |
Waters Corp
WAT
|
$6.45M |
| 3 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$5.16M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
$4.14M |
| 5 |
IQVIA
IQV
|
$4.06M |
Sector Composition
| 1 | Healthcare | 98.13% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
ANI Pharmaceuticals
ANIP
$2.04B
| $5.1M | 1.36% |
126,874
+8,933
| +8% | +$359K |
|
|
SILK
27
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $4.93M | 1.31% |
+93,305
| New | +$4.93M |
|
28
Day One Biopharmaceuticals
DAWN
$763M
| $4.83M | 1.29% |
224,483
+12,292
| +6% | +$265K |
|
|
PHLT
29
Performant Healthcare, Inc. Common Stock
PHLT
$602M
| $4.76M | 1.27% |
1,319,675
+296,325
| +29% | +$1.07M |
|
30
Procept Biorobotics
PRCT
$2.12B
| $4.67M | 1.24% |
112,318
+11,117
| +11% | +$462K |
|
31
Lantheus
LNTH
$3.76B
| $4.63M | 1.23% |
90,923
+51,241
| +129% | +$2.61M |
|
32
Rhythm Pharmaceuticals
RYTM
$6.84B
| $4.6M | 1.22% |
157,862
-30,127
| -16% | -$877K |
|
33
Legend Biotech
LEGN
$6.62B
| $4.59M | 1.22% |
91,932
-29,295
| -24% | -$1.46M |
|
|
34
Sarepta Therapeutics
SRPT
$2.01B
| $4.58M | 1.22% |
+35,314
| New | +$4.58M |
|
35
Schrodinger
SDGR
$1.4B
| $4.26M | 1.13% |
227,951
+104,272
| +84% | +$1.95M |
|
36
89bio
ETNB
$1.35B
| $4.24M | 1.13% |
332,880
+107,880
| +48% | +$1.37M |
|
37
Biogen
BIIB
$20.7B
| $4.21M | 1.12% |
+15,217
| New | +$4.21M |
|
38
Edwards Lifesciences
EW
$47.1B
| $4.07M | 1.08% |
54,579
-27,327
| -33% | -$2.04M |
|
39
Aclaris Therapeutics
ACRS
$219M
| $3.89M | 1.04% |
247,159
+13,533
| +6% | +$213K |
|
40
Arcellx
ACLX
$3.88B
| $3.75M | 1% |
121,093
-18,782
| -13% | -$582K |
|
|
KRTX
41
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $3.71M | 0.99% |
18,900
+6,900
| +58% | +$1.36M |
|
42
Transmedics
TMDX
$3.69B
| $3.42M | 0.91% |
55,351
+12,993
| +31% | +$802K |
|
43
Supernus Pharmaceuticals
SUPN
$2.51B
| $3.39M | 0.9% |
94,906
+5,197
| +6% | +$185K |
|
44
Cooper Companies
COO
$13.2B
| $3.31M | 0.88% |
10,000
-622
| -6% | -$206K |
|
|
45
IQVIA
IQV
$31.1B
| $3.15M | 0.84% |
15,374
-19,797
| -56% | -$4.06M |
|
|
46
Waters Corp
WAT
$17.3B
| $3.02M | 0.8% |
8,804
-18,826
| -68% | -$6.45M |
|
47
Kiniksa Pharmaceuticals
KNSA
$2.56B
| $2.87M | 0.76% |
191,307
+65,115
| +52% | +$975K |
|
48
Immunovant
IMVT
$2.74B
| $2.8M | 0.75% |
+158,006
| New | +$2.8M |
|
49
Alphatec Holdings
ATEC
$2.32B
| $2.8M | 0.75% |
226,867
-318,266
| -58% | -$3.93M |
|
50
Veracyte
VCYT
$2.38B
| $2.79M | 0.74% |
117,726
+56,843
| +93% | +$1.35M |
|